In the study, the drug was well-tolerated, stimulated immune T-cells that can attack AIDS virus-infected cells, and produced potent antibody responses with neutralizing activity against multiple HIV viral
Sanctura XR is the once-daily formulation of Sanctura, which is currently being marketed in the US. Esprit Pharma is co-promoting the treatment with Indevus and has agreed to
The patent covers methods used to create new treatments such as Evizon (squalamine lactate), squalamine and trodusquemine. These compounds have been identified as anti-angiogenic agents, antibiotics and sodium
GSK’s proposed acquisition of ID Biomedical reflects its desire to address the public health need for an increased supply of influenza vaccines, amid fears of a global influenza
The pre-investigational device exemption (IDE) application process is designed to provide companies that have unique diagnostic tests with informal input regarding what the FDA would look for in
Bacterial cell expression technology (BCE) is used to discover and screen, as well as develop and manufacture, recombinant proteins and antibodies. Currently there are two antibody products in
Fast track designation would have allowed for a rolling submission of the biologics license application (BLA), but Genentech will now have to submit a completed version of the
The trial is planned to enroll 108 patients with recurrent, metastatic non-small cell lung cancer (NSCLC) at 12 sites across the US and Canada. The study will evaluate
The completed study was designed to evaluate both the blood levels obtained by, as well as the relative safety of, three doses of lidocaine formulated with Columbia’s patented
Caliper is set to purchase NovaScreen for $22 million in stocks and cash plus payments of up to $8 million contingent on the achievement of defined revenue milestones
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.